Product
Hemin
2 clinical trials
2 indications
Indication
Acute Intermittent PorphyriaIndication
Hereditary CoproporphyriaClinical trial
Acute Porphyrias: Biomarkers for Disease Activity and Response to TreatmentStatus: Active (not recruiting), Estimated PCD: 2025-12-01
Clinical trial
Safety and Efficacy of Panhematin™ for Prevention of Acute Attacks of PorphyriaStatus: Terminated, Estimated PCD: 2023-12-27